https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-18 / Blood 2006 Aug;108(4):1298-305
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-18 / Blood 2006 Aug;108(4):1298-3052006-04-18 00:00:002019-02-15 09:25:36Antigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-18 / Eur. Urol. 2006 Jul;50(1):34-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-18 / Eur. Urol. 2006 Jul;50(1):34-432006-04-18 00:00:002019-02-15 09:17:02Therapeutic dendritic cell vaccination of patients with renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-15 / Clin. Cancer Res. 2006 Apr;12(8):2555-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-15 / Clin. Cancer Res. 2006 Apr;12(8):2555-622006-04-15 00:00:002019-02-15 09:22:14A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-13 / Cancer Immunol. Immunother. 2006 Nov;55(11):1432-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-13 / Cancer Immunol. Immunother. 2006 Nov;55(11):1432-422006-04-13 00:00:002019-02-15 09:24:15Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-13 / Cancer Immunol. Immunother. 2006 Dec;55(12):1524-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-13 / Cancer Immunol. Immunother. 2006 Dec;55(12):1524-332006-04-13 00:00:002019-02-15 08:53:03Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-11 / Zhonghua Yi Xue Za Zhi 2006 Apr;86(14):943-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-11 / Zhonghua Yi Xue Za Zhi 2006 Apr;86(14):943-62006-04-11 00:00:002019-02-15 09:23:49[Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-06 / Skin Pharmacol Physiol 2006;19(3):124-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-06 / Skin Pharmacol Physiol 2006;19(3):124-312006-04-06 00:00:002019-02-15 08:44:41Current state and perspectives of dendritic cell vaccination in cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-06 / Ann. Oncol. 2006 Jun;17(6):974-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-06 / Ann. Oncol. 2006 Jun;17(6):974-802006-04-06 00:00:002019-02-15 08:39:01Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Clin. Exp. Immunol. 2006 Apr;144(1):41-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Clin. Exp. Immunol. 2006 Apr;144(1):41-72006-04-01 00:00:002006-04-01 00:00:00Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Leuk. Lymphoma 2006 Apr;47(4):675-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Leuk. Lymphoma 2006 Apr;47(4):675-822006-04-01 00:00:002006-04-01 00:00:00Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies
